510(k) · Cleared
ClearedBard PTV Dilatation Catheter
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
C.R. Bard, Inc. · OMZ Pulmonary (Pulmonic) Valvuloplasty Catheters/Percutaneous Valvuloplasty Catheter
Cleared on Nov 2, 2012 as substantially equivalent to K102473 (NuMED, Inc., 2010) and 1 other predicate after an 88-day review. Its family tree reaches back 5 generations to 1993. 5 later devices descend from it.
- Decided
- Nov 2, 2012
- Review
- 88 days
- Class
- Class II
- Product code
- OMZ
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 5 generations to K933483 (1993). 10 ancestors in all. 5 later devices descend from it, 1 citing it directly.
- Root · 5 generations backK933483 Opti-Plast 5F Pta CathetersVas-Cath, Inc. · 1993
- 4 generations backK973013 Opti-Plast (Centurion) 5.5F Angioplasty CatheterVas-Cath, Inc. · 1998
- 3 generations backK040243 Bard Atlas Pta Balloon Dilatation CatheterC.R. Bard, Inc. · 2004
- 2 generations backK052236 Bard Atlas Pta Balloon Dilatation CatheterBard Peripheral Vascular, Inc. · 2005
- 1 generation backK120971 Atlas Pta Balloon Dilatation CatheterBard Peripheral Vascular, Inc. · 2012
- This deviceK122367 Bard PTV Dilatation CatheterC.R. Bard, Inc. · 2012
- Descendant · cites it directly · 4 of its ownK131002 Vida PTV Dilataton CatheterC.R. Bard, Inc. · 2013
- Descendant · 2 generations on · 3 of its ownK141985 True BA V Balloon Valvuloplasty CatheterC.R. Bard, Inc. · 2014
- Descendant · 2 generations on · 2 of its ownK212588 Conquest 40 PTA Dilatation Catheter, Atlas Gold PTA Dilatation…C.R. Bard, Inc. · 2022
- Descendant · 3 generations on · 1 of its ownK241040 Amethyst HP PTA OTW 0.035 CatheterNatec Medical, Ltd. · 2024
- Descendant · 4 generations on · 0 of its ownK251915 Amethyst HP PTA OTW 0.035 CatheterNatec Medical, Ltd. · 2025
Most influential descendants
Showing 5 of 5 · See all- K131002Vida PTV Dilataton CatheterC.R. Bard, Inc. · 2013 · cites it directly4descendants
- K141985True BA V Balloon Valvuloplasty CatheterC.R. Bard, Inc. · 2014 · 2 generations on3descendants
- K212588Conquest 40 PTA Dilatation Catheter, Atlas Gold PTA Dilatation Catheter, Vida PTV…C.R. Bard, Inc. · 2022 · 2 generations on2descendants
- K241040Amethyst HP PTA OTW 0.035 CatheterNatec Medical, Ltd. · 2024 · 3 generations on1descendant
- K251915Amethyst HP PTA OTW 0.035 CatheterNatec Medical, Ltd. · 2025 · 4 generations on0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −5 | K933483 | Opti-Plast 5F Pta Catheters | Vas-Cath, Inc. | 1993 | — |
| −4 | K973013 | Opti-Plast (Centurion) 5.5F Angioplasty Catheter | Vas-Cath, Inc. | 1998 | — |
| −3 | K040243 | Bard Atlas Pta Balloon Dilatation Catheter | C.R. Bard, Inc. | 2004 | — |
| −2 | K052236 | Bard Atlas Pta Balloon Dilatation Catheter | Bard Peripheral Vascular, Inc. | 2005 | — |
| −1 | K120971 | Atlas Pta Balloon Dilatation Catheter | Bard Peripheral Vascular, Inc. | 2012 | — |
| 0 (this device) | K122367 | Bard PTV Dilatation Catheter | C.R. Bard, Inc. | 2012 | — |
| +1 | K131002 | Vida PTV Dilataton Catheter | C.R. Bard, Inc. | 2013 | — |
| +2 | K141985 | True BA V Balloon Valvuloplasty Catheter | C.R. Bard, Inc. | 2014 | — |
| +2 | K212588 | Conquest 40 PTA Dilatation Catheter, Atlas Gold PTA Dilatation Catheter, Vida… | C.R. Bard, Inc. | 2022 | — |
| +3 | K241040 | Amethyst HP PTA OTW 0.035 Catheter | Natec Medical, Ltd. | 2024 | — |
| +4 | K251915 | Amethyst HP PTA OTW 0.035 Catheter | Natec Medical, Ltd. | 2025 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1993 | 1 | 0 |
| 2002 | 2 | 0 |
| 2010 | 1 | 0 |
| 2011 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2013 | 1 | 0 |
| 2014 | 1 | 0 |
| 2022 | 1 | 0 |
| 2024 | 1 | 0 |
| 2025 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in OMZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
- Candidate predicates for a device like this, rankedin the report
- Recall history across each candidate’s familyin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K102473 | Mullins-X PTV CatheterSummary page 1…OMZ) Classification: Class 11 Classification Panel: Cardiovascular Predicate Devices: * Mullins-X PTV Catheter (K102473; cleared December 9, 2010) * Atlas"' PTA Balloon Dilatation Catheter (K120971, cleared April 19, 2012) Bard Peripheral Vas… | 2010 |
| * | K120971 | Atlas Pta Balloon Dilatation CatheterSummary page 1…ion Panel: Cardiovascular Predicate Devices: * Mullins-X PTV Catheter (K102473; cleared December 9, 2010) * Atlas"' PTA Balloon Dilatation Catheter (K120971, cleared April 19, 2012) Bard Peripheral Vascular, Inc. EMIL Tra… | 2012 |
What descends from it? (5)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K131002 | Vida PTV Dilataton Catheter | 2013 | 4 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 19 years and passes through 3 companies; a new generation was cleared every 4.7 years on median.
- None of the 10 ancestors has a recall.
- Of its descendants, K131002 (C.R. Bard, Inc., 2013) has gone furthest, with 4 descendants of its own.
How does its category compare?
All OMZ devicesOMZ Pulmonary (Pulmonic) Valvuloplasty Catheters/Percutaneous Valvuloplasty Catheter: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.
FDA decisions per year · OMZ
1in 2016
2026 to Oct 25, outlined.
Median 510(k) review, days · OMZ
Too few OMZ 510(k)s in any year since 2007 to give a median.
Recalls per year · OMZ
No recall names OMZ since 2007.
Adverse event reports per year · OMZ
3in 2024
MAUDE reports naming product code OMZ, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 0 | — | 0 | 0 |
| 2009 | 0 | — | 0 | 0 |
| 2010 | 1 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 0 |
| 2012 | 1 | — | 0 | 0 |
| 2013 | 1 | — | 0 | 1 |
| 2014 | 0 | — | 0 | 1 |
| 2015 | 0 | — | 0 | 3 |
| 2016 | 1 | — | 0 | 2 |
| 2017 | 0 | — | 0 | 0 |
| 2018 | 0 | — | 0 | 1 |
| 2019 | 0 | — | 0 | 4 |
| 2020 | 0 | — | 0 | 0 |
| 2021 | 0 | — | 0 | 5 |
| 2022 | 0 | — | 0 | 0 |
| 2023 | 0 | — | 0 | 1 |
| 2024 | 0 | — | 0 | 3 |
| 2025 | 0 | — | 0 | 0 |
| 2026 | 0 | — | 0 | — |
What is it indicated for?
The Bard PTV Dilatation Catheters are recommended for
Percutaneous Transluminal Valvuloplasty (PTV) of the pulmonary valve.
* A patient with isolated pulmonary stenosis
* A patient with valvular pulmonary stenosis with other minor congenital heart
disease that does not require surgical intervention.
Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.
https://510kreport.com/device/K122367 · printed Nov 6, 2026
Cite this page
510(k) Report. “K122367: Bard PTV Dilatation Catheter.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K122367
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026